AU532375B2 - Latex reagent - Google Patents
Latex reagentInfo
- Publication number
- AU532375B2 AU532375B2 AU55610/80A AU5561080A AU532375B2 AU 532375 B2 AU532375 B2 AU 532375B2 AU 55610/80 A AU55610/80 A AU 55610/80A AU 5561080 A AU5561080 A AU 5561080A AU 532375 B2 AU532375 B2 AU 532375B2
- Authority
- AU
- Australia
- Prior art keywords
- hcg
- chain
- beta
- aqueous solution
- molar aqueous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Reproductive Health (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Peptides Or Proteins (AREA)
- Materials For Medical Uses (AREA)
- Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
- Tires In General (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
Abstract
1. An immunological diagnostic reagent for the determination of pregnancy by means of HCG determination and latex agglutination containing discrete particles of an immunologically inert latex polymer having a particle size of 0.01 to 0.9 mu m and a specific weight of 0.01 to 1.1, to which human choriongonadotropin (HCG) has been covalently bound via an amide bridge with a carbodiimide coupling agent at a pH of 5-8, characterized in that the HCG is used in the form of its beta-chain, whereby this beta-chain is substantially free from the alpha-chain and whereby this beta-chain has been separated from the alpha-chain by treating partially purified HCG containing 2000-5000 IU/mg of HCG for 1/2 to 2 hours at a pH of 4-5.5 and a temperature of 20-50 degrees C with a chaotropic agent, namely with a 7-10 molar aqueous solution of urea, a 7-10 molar aqueous solution of lithium bromide, a 4.5-6 molar aqueous solution of guanidine hydrochloride or a 2-3 molar aqueous solution of ammonium thiocyanate, subsequently adjusting the pH of the reaction mixture to 7.5 and separating the mixture of HCG/chaotropic agent by ion exchange and/or further conventional methods in accordance with which molecules can be separated on the basis of differences in the elektrostatic charge, and whereby neither the partially purified HCG nor the beta-chain thereof have been purified further.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1262979A | 1979-02-16 | 1979-02-16 | |
US12629 | 1979-02-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU5561080A AU5561080A (en) | 1980-08-21 |
AU532375B2 true AU532375B2 (en) | 1983-09-29 |
Family
ID=21755912
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU55610/80A Ceased AU532375B2 (en) | 1979-02-16 | 1980-02-15 | Latex reagent |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0014965B1 (en) |
JP (1) | JPS55160854A (en) |
AT (2) | ATE10034T1 (en) |
AU (1) | AU532375B2 (en) |
CA (1) | CA1119924A (en) |
DE (1) | DE3069477D1 (en) |
DK (1) | DK153590C (en) |
ES (1) | ES8103843A1 (en) |
FI (1) | FI72822C (en) |
NO (1) | NO156546C (en) |
NZ (1) | NZ192872A (en) |
ZA (1) | ZA80887B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL63855A (en) * | 1981-09-16 | 1984-10-31 | Teva Pharma | Method and kit for detecting pregnancy |
US4543339A (en) * | 1982-03-16 | 1985-09-24 | Oneill Christopher | Early pregnancy detection by detecting enhanced blood platelet activation |
JPS6157856A (en) * | 1984-08-29 | 1986-03-24 | Chemo Sero Therapeut Res Inst | Method for measuring hormone |
JPS63305251A (en) * | 1987-06-05 | 1988-12-13 | Dai Ichi Pure Chem Co Ltd | Immunoassay utilizing latex aggregation reaction |
JPS64169U (en) * | 1987-06-22 | 1989-01-05 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3992514A (en) * | 1972-07-17 | 1976-11-16 | Istituto Farmacologico Serono S.P.A. | Radioimmunoassay method for human chorionic gonadotropin in the presence of luteinizing hormone |
US4123509A (en) * | 1974-12-19 | 1978-10-31 | American Home Products Corporation | Pregnancy test |
US4140662A (en) * | 1977-03-25 | 1979-02-20 | Ortho Diagnostics, Inc. | Attachment of proteins to inert particles |
CA1101330A (en) * | 1977-09-19 | 1981-05-19 | Ernst A. Fischer | Immunological material bonded to carboxylated latex polymer and process for making it |
US4138214A (en) * | 1977-12-19 | 1979-02-06 | American Home Products Corporation | Diagnostic test utilizing human chorionic gonadotropin |
US4234561A (en) * | 1978-02-06 | 1980-11-18 | Research Corporation | Antigen for early pregnancy test and contraceptive vaccine |
-
1980
- 1980-02-14 DE DE8080100755T patent/DE3069477D1/en not_active Expired
- 1980-02-14 NZ NZ192872A patent/NZ192872A/en unknown
- 1980-02-14 EP EP80100755A patent/EP0014965B1/en not_active Expired
- 1980-02-14 CA CA000345609A patent/CA1119924A/en not_active Expired
- 1980-02-14 AT AT80100755T patent/ATE10034T1/en not_active IP Right Cessation
- 1980-02-15 FI FI800458A patent/FI72822C/en not_active IP Right Cessation
- 1980-02-15 AT AT0083880A patent/AT365201B/en not_active IP Right Cessation
- 1980-02-15 AU AU55610/80A patent/AU532375B2/en not_active Ceased
- 1980-02-15 NO NO800426A patent/NO156546C/en unknown
- 1980-02-15 ZA ZA00800887A patent/ZA80887B/en unknown
- 1980-02-15 DK DK068480A patent/DK153590C/en active
- 1980-02-15 ES ES489277A patent/ES8103843A1/en not_active Expired
- 1980-02-15 JP JP1669980A patent/JPS55160854A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
DK153590B (en) | 1988-07-25 |
AT365201B (en) | 1981-12-28 |
NO156546B (en) | 1987-06-29 |
ES489277A0 (en) | 1981-03-16 |
FI72822C (en) | 1987-07-10 |
ZA80887B (en) | 1981-02-25 |
CA1119924A (en) | 1982-03-16 |
EP0014965A1 (en) | 1980-09-03 |
NO156546C (en) | 1987-10-07 |
EP0014965B1 (en) | 1984-10-24 |
JPS6253773B2 (en) | 1987-11-12 |
DK68480A (en) | 1980-08-17 |
FI800458A (en) | 1980-08-17 |
NO800426L (en) | 1980-08-18 |
DK153590C (en) | 1988-12-12 |
ES8103843A1 (en) | 1981-03-16 |
ATA83880A (en) | 1981-05-15 |
FI72822B (en) | 1987-03-31 |
ATE10034T1 (en) | 1984-11-15 |
NZ192872A (en) | 1983-03-15 |
AU5561080A (en) | 1980-08-21 |
JPS55160854A (en) | 1980-12-15 |
DE3069477D1 (en) | 1984-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Dandliker et al. | The effect of chaotropic ions on the dissociation of antigen-antibody complexes | |
Funakoshi et al. | Human Carbonic Anhydrases: I. Isolation and demonstration of isozymes in erythrocytes | |
CA1075153A (en) | Competitive immunoassay for thyroid hormone using polyacrylamide particles | |
EP0420913A4 (en) | Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same | |
AU532375B2 (en) | Latex reagent | |
ES485763A1 (en) | Method and composition for direct determination of iron in blood serum | |
Prather et al. | Evidence for activities of rabbit reticulocyte elongation factor 1 analogous to bacterial factors EF-Ts and EF-Tu | |
DE69409372T2 (en) | IMMUNOASSAY METHOD USING ZETA POTENTIAL | |
EP0379133B2 (en) | Use of divalent cations in immunochemical tests | |
US4218335A (en) | Stabilizer for an immunochemical measuring reagent | |
HU186928B (en) | Immunochemical reagent preparation | |
EP0266686B1 (en) | Latex agglutination method for the detection of an antibody against streptococcus deoxyribonuclease b | |
Gheţie et al. | Multivalent hybrid antibody | |
Evans et al. | The agglutination of ion exchange resin particles coated with polysaccharide | |
CA1060794A (en) | Composition and method for the determination of pregnancy | |
AU7281281A (en) | Binding and separating in competitive radioimmunoassay | |
Hurley et al. | Haemolysis and reversible agglutination of trypsinized normal red cells by a normal human serum | |
Solheim | Kinetics of the Reaction between a Monoclonal IgM Anti‐I and Rabbit Red Cells: II. Activity of Subunits and Fab′ μ‐Fragments. | |
SE8601645D0 (en) | IMMUNOLOGICAL PROCEDURE | |
Gaiseanu | Boron diffusion in silicon: Physical analysis. | |
Veynblat et al. | Suspension diagnosticum for studies on plague bacillus endotoxin and homologous antibodies. |